5 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Multi-dimensional omics approach to stratification of patients with low back pain (PAIN-OMICS)
Date du début: 1 sept. 2013, Date de fin: 31 août 2018,
"Pain-OMICS is a multidisciplinary consortium of leading clinical, academic and SME researchers in pain and different omics technologies. Genome-wide association studies identified a number of loci associated with pain, but the level of knowledge about underlying mechanisms of different pain syndromes as well as individual variation in the disease course remains inadequate. Pain-OMICS will capital ...
Voir le projet
11
Participants partenaires
TERMINÉ
Diagnostic and prognostic biomarkers for inflammatory bowel disease IBD-BIOM (IBD-BIOM)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,
...IBD are unsatisfactory. Development of biomarkers allowing insights into pathogenesis, prognosis and targeted therapy is a major unmet need. This programme addresses that need. IBD-BIOM is a multidisciplinary consortium of leading academic and industrial SME researchers in inflammatory bowel disease, genomics, glycomics, glycoproteomics and activomics. Recent genome-wide association studies perfor ...
Voir le projet
11
Participants partenaires
TERMINÉ
Kinetoplastid Drug Development: strengthening the preclinical pipeline (KINDRED)
Date du début: 1 sept. 2013, Date de fin: 31 août 2016,
...frican trypanosomiasis (HAT) and Chagas disease (CD), continue to impart a heavy toll on human health. The treatments available are limited and threatened by drug resistance with few newdrugs in the pipeline. The KINDReD consortium integrates five leading academic laboratories in Europe (Portugal, United Kingdom, and Switzerland), the USA (California) and South America (Brazil) with high throughpu ...
Voir le projet
14
Participants partenaires
TERMINÉ
Transferring Activomics into the Clinical Setting (TACTICS)
Date du début: 1 déc. 2015, Date de fin: 31 mai 2016,
...jor toll on public health and a concomitant heavy economic burden for the healthcare system and taxpayer. Better diagnosis and targeted therapy of IBD would reduce suffering and costs alike. We participate in this call in order to achieve this goal, allowing us to devise a comprehensive business plan that will act as a roadmap to bring our biomarker into clinical diagnostic laboratories. SME-phase ...
Voir le projet
1
Participant partenaire
TERMINÉ
Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LEISHDRUG)
Date du début: 1 oct. 2008, Date de fin: 31 mars 2012,
...ct promastigote stage and the vertebrate aflagellate amastigote stage that proliferates inside infected host macrophages provoking the pathology of the disease. This consortium uses a highly interdisciplinary approach to reveal Leishmania signaling molecules associated with amastigote virulence, with the major aim to exploit parasite-specific pathways for anti-leishmanial drug development. We use ...
Voir le projet